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Our goal was to examine anthropometric measures of central and overall adiposity as 
predictors of all-cause and cardiovascular disease (CVD) mortality. 
 
Methods:  
Subjects included 2091 men and 2227 women in the Singapore Cardiovascular Cohort 
Study. Over a mean follow up of 12.0 years, there were 202 deaths of which 70 were 
due to CVD. Body mass index (BMI), waist circumference (WC) and waist-to-hip 
ratio (WHR) were obtained from direct anthropometric measurements. Waist residual 
(WR) was the residual after regressing WC on BMI in each gender group.  
 
Results:  
The associations between BMI, WC, WHR and all-cause mortality in men were 
U-shaped and persisted for BMI after adjusting for central obesity indicators. A 
U-shaped association was also found between WC and CVD mortality in men. 
However, a linear association between WHR and CVD mortality was found in women 
after adjusting for BMI. WR was marginally associated with all-cause mortality in 
women independently of BMI.  
 
Conclusions: 
In this cohort general adiposity appears to be a significant predictor of all-cause 
mortality in men, more so than central adiposity. Although measures of central 
adiposity were better predictors of CVD mortality in both men and women as 
compared with measures of general adiposity, there was a difference in that the 
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According to the World Health Organization (WHO), obesity is defined as a condition 
with excessive fat accumulation in the body to the extent that health and well-being 
are adversely affected [1]. The current view of fatness is that fat collectively 
constitutes an endocrine organ which plays a wide-ranging role in metabolic 
regulation and physiological homeostasis [2]. In the past few decades, obesity is 
becoming more common, and is becoming the most significant cause of ill-health and 
threat of health [3, 4].  
 
The prevalence of obesity in Asia has increased at an alarming rate, in conjunction 
with an increase in obesity-related diseases [5, 6]. The causes of this rapid increase 
within the region are likely to be complex. Although studies indicate a possible 
genetic susceptibility to obesity in some minority groups, environmental factors also 
play a significant role. Increasing economic developments of Asian countries 
contribute to the increasing prevalence of obesity [7]. Our current „obesogenic‟ 
environment facilitates the development of obesity by providing virtually unlimited 
access to inexpensive, energy-dense food while decreasing the need for prolonged 
periods of physical activity [3, 8]. Whereas many recognize the significant risk of 
cardiovascular disease (CVD) and diabetes mellitus associated with excess body fat, a 
myriad of other health problems can accompany overweight and obesity, potentially 
leading to early morbidity and mortality [9].  
 
The health impact of fatness is particularly troubling because obesity prevalence in 
Singapore has increased dramatically and effective strategies to alleviate the societal 
burden of obesity are needed [7]. Given the link between fatness and morbidity and 
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mortality, excessive fatness is now recognized as one of the most serious public health 
challenges [10-12]. Prevention, prompt diagnosis and management of obesity in 
Singapore are crucial. Better knowledge on the association between obesity and 
mortality could aid better disease prevention and early detection of diseases among 
individuals [5, 13].  
 
To date, it is unclear which measure of obesity is the most appropriate for risk 
stratification and death prediction. In light of the growing epidemic of obesity, it is 
increasingly important to identify individuals that are at particularly high risk of 
obesity-related mortality. In general, Body mass index (BMI) is still used as the main 
criterion to prompt behavioral, medical or surgical interventions against obesity [14, 
15]. However, BMI does not distinguish between overweight due to muscle or fat 
accumulation [16]. Moreover, visceral rather than subcutaneous fat accumulation is 
associated with increased secretion of free fatty acids, hyperinsulinemia, insulin 
resistance, hypertension and dyslipidemia [17]. There is an agreement that abdominal 
obesity is a better indicator of cardiovascular risk than BMI [18-20]. However, the 
studies available to date have not given a conclusive answer as to which 
anthropometric measure better predicts CVD and all-cause mortality.  
 
In this paper, the association between obesity and mortality among Singaporeans will 
be explored. In the following chapter, I will give a throughout review of the literature 
on obesity and CVD and all-cause mortality. In Chapter 3 to 4, I will discuss the aim, 
methodology and results of the study. In Chapter 5, I will give a detail account on the 
discussion on the findings and limitations of the study. In Chapter 6, I will discuss the 









Chapter 2  
 
2. Literature Review 
 
2.1 Prevalence of Obesity 
 
Obesity has reached epidemic proportions globally [21, 22] (In the studies cited below, 
unless otherwise mentioned, overweight refers to a BMI between 25.0 and 29.9, and 
obesity as BMI  30.0 kg/m2). According to WHO, between 1980 and 2008, the 
prevalence of obesity has nearly doubled. Between 1980 and 2008, obesity prevalence 
rose from 4.8% to 9.8% in men and from 7.9% to 13.8% in women [22]. In 2008, 
more than 1.4 billion adults were overweight and more than half a billion were obese 
[22]. In the United States in 2009-2010, 35.5% of men and 35.8% of women had 
obesity [23]. 
 
Though Asia is home to some of the leanest populations on the globe, obesity has 
become a serious and growing problem across the region over the past two decades 
[24, 25]. In Asia, many countries are dealing with a rise in obesity [24-26]. China and 
India are the most populous nations on the planet, hence a small percentage increase 
in obesity rate would translate into millions more cases of chronic diseases. In China, 
from 1993 to 2009, obesity (defined as BMI of 27.5 or higher) increased from about 3 
percent to 11 percent in men and from about 5 percent to 10 percent in women. 
Abdominal obesity (defined as waist circumference [WC] of 90 centimeters or higher 
in men, and 80 centimeters or higher in women) also increased during this time period, 
from 8 percent to 28 percent in men and 28 percent to 46 percent in women [27]. In 
India, recent data in 2005 reported 14 percent of women aged 18 to 49 were 
overweight or obese. The rate of overweight and obesity in women, overall, increased 
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by 3.5 percent a year from 1998 to 2005 [26].  
 
As part of a worldwide phenomenon, obesity is increasing in prevalence in Singapore 
[28]. The latest National Health Survey shows the obesity rate has increased from 6.9 
percent in 2004 to 10.8 percent in 2010 [29]. Singapore needs to “act now” to prevent 
obesity from becoming a diabetes epidemic.  
 
2.2 Impact of Obesity   
 
Obesity is a complex, multifactorial condition [2, 30]. The pathogenic link between 
increased adipose tissue mass and higher risk for obesity-related disorders is related to 
adipose tissue dysfunction and ectopic fat accumulation [31]. Ectopic fat 
accumulation including visceral obesity is characterized by changes in the cellular 
composition, increased lipid storage and impaired insulin sensitivity in adipocytes and 
secretion of a proinflammatory adipokine pattern [9, 31, 32]. Increase in body fat 
alters the body‟s response to insulin, potentially leading to insulin resistance and the 
risk of thrombosis [33]. Many endogenous genetic, endocrine and inflammatory 
pathways and environmental factors are involved in the development of 
obesity-related diseases [9, 31].  
 
Obesity carries substantial health implications for both chronic diseases and mortality. 
Obese individuals have an increased risk of developing some of the most prevalent, 
yet costly diseases. Because of its maladaptive effects on various cardiovascular risk 
factors and its adverse effects on cardiovascular structure and function, obesity has a 
major impact on cardiovascular diseases, such as heart failure, coronary heart disease, 
sudden cardiac death, and atrial fibrillation [34]. A myriad of other health problems 
can accompany overweight and obesity, including type 2 diabetes, hypertension, 
several forms of cancer (endometrial, postmenopausal breast, kidney and colon), 
musculoskeletal disorders, sleep apnea and gallbladder disease [30]. In addition, 
obesity may contribute to debilitating health problems such as osteoarthritis and 
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pulmonary diseases and is related to stress, anxiety and depression [35]. In light of the 
overwhelming evidence linking obesity to disease risk, it is no surprise that obesity 
has been shown to increase the risk of all-cause mortality [36]. Overweight and 
obesity rank fifth as worldwide causes of death among risk factors [37]. At least 2.8 
million people each year die from complications as a result of being overweight or 
obese [38]. Epidemiological studies suggest that obesity is an important predictor of 
longevity [39-41]. In the Framingham Heart Study, the risk of death within 26 years 
increased by 1% for each extra pound gained between the ages of 30 years and 42 
years and by 2% between the ages of 50 years and 62 years [39]. A meta-analysis 
based on person-level data from twenty-six observational studies also documented 
excess mortality associated with obesity [40]. The Prospective Studies Collaboration 
in Western Europe and North American reported BMI is a strong predictor of overall 
mortality [42]. In pooled analyses among more than 1 million Asians, the excess risk 
of death associated with a high BMI was seen among East Asians [41]. 
 
The cost of obesity and its associated comorbidities are staggering, both in terms of 
quality of life and health care expenditure [21]. Obese individuals report impaired 
quality of life. In the Unites States, obese men and women lost 1.9 million and 3.4 
million quality-adjusted life years, respectively, per year relative to their normal 
weight counterparts [43]. Worldwide, an estimated 35.8 million (2.3%) of global 
disability-adjusted life years are caused by overweight or obesity [38]. The costs from 
health care and lost productivity to the individual and society are also substantial. A 
recent study in US estimated that medical expenditures of health complications 
attributed to overweight and obesity may have reached 78.5 billion dollars [44].  
 
Taken together, obesity has taken a toll on the health and quality of life of people, and 
the global economy. This makes obesity one of the biggest public health challenges of 
the 21st century. Today, cancer, CVD and diabetes are among the top ten disease 
conditions affecting Singaporeans and they account for more than 60 percent of all 
deaths [45]. These facts and the increasing prevalence of obesity make it an important 
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health problem. In spite of the discovery of new mechanisms of these diseases, the 
prevention and treatment of obesity remains an open problem.  
 
2.3 Assessment of Obesity  
 
Body fat can be measured in several ways. Some are simple, requiring only a tape 
measure, such as anthropometric measures. Others use expensive equipments to 
precisely estimate fat mass, muscle mass, and bone density, such as dual X-ray 
absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging 
(MRI) [46-48]. Each body fat assessment method has its pros and cons. Imaging 
techniques such as MRI or CT are now considered to be the most accurate methods 
[48]. MRI, CT or DXA scans are typically used in research settings since it is 
expensive and immobile [49]. Simple anthropometric measurements such as BMI, 
WC and WHR have more practical value in both clinical practice and large-scale 
epidemiological studies and are the most widely used methods to measure body fat 
and fat distribution [14]. The distinct advantages of anthropometric methods are that 
they are portable, non-invasive, inexpensive, making them useful in field studies [14, 
47, 50].  
 
2.3.1 BMI  
 
BMI is a simple marker to reflect total body fat amount [51]. It is commonly accepted 
as a general measure of overweight and obesity. It is calculated by dividing the 
patient‟s weight in kilograms by the square of the individual‟s height in meters. 
According to WHO, adults with a BMI in the range of 25 to 29.9 are classified as 
overweight, and those with a BMI of more than 30 are classified as obese. For Asian 
populations, including Singapore, lower BMI cut offs are used: Low risk BMI (kg/m
2
) 
= 18.5 to 22.9; Moderate risk BMI (kg/m
2
) = 23.0 to 27.4; High risk BMI (kg/m
2
) = 




BMI is the most frequently used measure of obesity because of the robust nature of 
the measurements of weight and height [14]. BMI forms the backbone of the obesity 
classification system [52]. It is an important screening tool to assess patients with 
excess body weight and stratify treatments according to the likelihood of underlying 
disease risk [53]. The determination of BMI may provide a determination of global 
disease risk. Because BMI is relatively highly correlated with body fat, it is often used 
in epidemiologic studies to assess adiposity and is frequently used to estimate the 
prevalence of obesity within a population [15, 53]. However, BMI does have some 
limitations. As compared to weight and height, BMI is just an index of weight excess, 
rather than body fatness composition [51]. BMI does not take into account the 
variation in body fat distribution and abdominal fat mass, which can differ greatly 
among populations and can vary substantially within a narrow range of BMI [32]. In 
addition, BMI is a limited diagnostic tool in very muscular individuals and those with 
little muscle mass, such as elderly patients [13].  
 
2.3.2 WC and WHR 
 
One important category of obesity not captured by BMI is “abdominal obesity”  the 
extra fat found around the middle that is an important factor in health [17, 24]. 
Regional obesity measures, including WC and wait-to-hip ratio (WHR), provide 
estimates of abdominal adiposity, which is related to the amount of visceral adipose 
tissue [14, 32].  
 
WC is commonly used to complement BMI when characterizing obesity. WC could 
provide important additional prognostic information, especially when BMI is not 
substantially increased but an unhealthy level of excessive adiposity is still suspected 
[54, 55]. A recent WHO report summarized evidence for WC as an indicator of 
disease risk [56]. WC correlates with abdominal obesity, and the presence of 
abdominal obesity confers a higher absolute disease risk [56, 57]. WC is an important 




WHR is the ratio of the circumference of the waist to that of the hips. WHR is more 
complicated to measure and more prone to measurement error because it requires two 
measurements [14]. In general, obesity can be classified into central or peripheral 
obesity [30]. In central obesity, the distribution of fat is commonly on the upper part 
of the trunk. However, in the peripheral type of obesity, the distribution of fat is 
mainly on the hip and thighs. WHR is a measure of body fat distribution or body 
shape. WHR was shown to be a good predictor of health risk [29]. However, WHR is 
more complex to interpret than WC, since increased WHR can be caused by increased 
abdominal fat or decrease in lean muscle mass around the hips [14]. 
 
2.4 Previous Studies on Anthropometric Measurements of Obesity 
and Mortality  
 
BMI has been routinely used in clinical and public health practice for decades to 
identify individuals and populations at risk of diseases and death [58]. Many studies 
have evaluated the relationship between BMI and mortality [40, 59-62]. In recent 
years, BMI has been criticized as a measure of risk because it reflects both fat and 
lean mass [63]. Multiple studies worldwide have shown that overweight subjects have 
similar or better outcomes for survival and cardiovascular events when compared to 
people classified as having normal body weight [12, 64]. Results of these studies 
suggest intrinsic limitations of BMI to differentiate adipose tissue from lean mass in 
intermediate BMI range [63, 64].  
 
An increasing amount of knowledge has been gathered about the metabolic 
consequences of central fat distribution [65, 66]. Greater abdominal adiposity is 
strongly associated with insulin resistance, dyslipidemia and systematic inflammation, 
factors that play essential roles in the pathogenesis of CVD [66]. WC or WHR as 
indicators of abdominal obesity may be better predictors of the risk of death than BMI, 
an indicator of overall obesity [55, 67-71]. Although a number of epidemiological 
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studies have demonstrated that measures of abdominal adiposity significantly predict 
chronic diseases such as CVD and diabetes mellitus independently of overall body 
adiposity, the associations of these measures with premature death have not been 
widely studied and previous findings have been inconsistent [19, 55, 67-73]. The 
inconsistencies may be due to differences in study populations, sampling, measures 
and analytic approaches [55].  
 
Given the inconsistency of prior results and the potential impact of central obesity on 
mortality outcomes, we performed a review of the current evidence for the association 
between anthropometric measures of adiposity and the risk of mortality. 
 
2.4.1 Search Strategy and Pitfalls of Literature Review  
 
Pubmed was used to identify relevant articles published from 1990 to October 1, 2012, 
by using a combination of keywords: “anthropometry”, “obesity”, “body mass index”, 
“waist circumference”, “waist-to-hip ratio” and “mortality”. One hundred and twenty 
three articles were indentified. A first selection of articles was made based on title. 
Only articles with titles relevant to the topic of our study were selected. Of the 123 
articles, 22 had appropriate titles and we read their abstracts to evaluate their 
relevance reducing the number of articles to 13. After that, the full text articles were 
read and 7 articles were selected since these studies are more relevant to our research 
questions. 
 
There are some limitations in the search strategy. First, we only searched for relevant 
studies in Pubmed. Other databases were not searched. Second, the articles included 
are all from publications in peer-reviewed journals. Non-English language journals 
were not included. Third, reference lists from relevant publications were not included 
in our review. Fourth, the included studies are all epidemiologic studies. Non-human 




2.4.2 Studies comparing BMI, WC, WHR and Mortality in Adults  
 
The largest study in this respect is the European Prospective Investigation on Cancer 
(EPIC) study in 359,387 participants from nine European countries with 14,723 
deaths during a follow-up of 9.7 years on average [67]. For all-cause mortality, there 
was a strong relationship between increased WC and WHR in both men and women. 
Relative risks (RRs) among men and women in the highest quintile of WC as 
compared with the lowest quintile were 2.05 (95% confidence interval [CI], 1.80 to 
2.33) and 1.78 (95% CI 1.56 to 2.04), respectively, and in the highest quintile of 
WHR as compared with the lowest quintile, the RRs were 1.68 (95% CI, 1.53 to 1.84) 
and 1.51 (95% CI, 1.37 to 1.66), respectively. The study suggested that both general 
adiposity and abdominal adiposity are associated with the risk of death and support 
the use of WC or WHR in addition to BMI in assessing the risk of all-cause mortality.   
 
Welborn and Dhaliwal showed in a study that followed 9309 Australian urban adults 
aged 20–69 years for 11 years that WHR was superior to BMI and WC in predicting 
all-cause mortality (male hazard ratio [HR]: 1.25, P=0.003; female HR: 1.24, P=0.003 
for an increase in 1 standard deviation [SD]) and CVD mortality (male HR: 1.62, 
P<0.001; female HR: 1.59, P<0.001 for an increase in 1 SD ) [74]. 
 
Based on 22,426 adults from a nationally representative sample of the Scottish 
population, Hotchkiss and Leyland found that BMI-defined obesity (≥ 30.0 kg/m2) 
was not associated with increased risk of mortality (HR=0.93; 95% CI: 0.80-1.08), 
whereas the overweight category was associated with a decreased risk (HR=0.80; 
95%CI: 0.70-0.91). A low BMI (<18.5 kg/m
2
) was associated with elevated HR for 
all-cause mortality (HR=2.66; 95% CI: 1.97-3.60). The reference group is the normal 
BMI category (18.5-25 kg/m
2
). In contrast, the HR for a high WC (men>102 cm, 
women>88 cm) was 1.17 (95% CI: 1.02-1.34) as compared with the reference WC 
group (men: 79-94 cm, women: 68-80 cm) and a high WHR (men>1, women>0.85) 
was 1.34 (95% CI: 1.16-1.55) as compared with the reference WHR group (men: 
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0.85-0.95, women: 0.7-0.8). There was an increased risk of CVD mortality associated 
with BMI-defined obesity, a higher WC and a higher WHR categories. The HR 
estimates for these were 1.36 (1.05-1.77), 1.41(1.11-1.79), 1.44(1.12-1.85), 
respectively [75]. 
 
Simpson and colleagues followed 16,969 men and 24,344 women for 11 years who 
were participants in the Melbourne Collaborative Cohort Study and aged 27–75 years 
at baseline [76]. Comparing the top quintile to the second quintile, for men there was 
an increased risk of between 20 and 30% for all-cause mortality for all anthropometric 
measures (BMI, WC and WHR). Comparing the top quintile to the second quintile, 
for women, there was an increased relative risk for WC (RR: 1.3; 95% CI: 1.1–1.6) 
and WHR (RR: 1.5; 95% CI: 1.2–1.8). Measures of central obesity were better 
predictors of mortality in women in this cohort study compared with measures of 
overall adiposity.  
 
In the Nurse‟s Health Study, a prospective cohort study of 44,636 women, 
associations of abdominal adiposity with all-cause and CVD mortality were examined 
[55]. During 16 years of follow-up, 3507 deaths were identified. After adjustment for 
BMI and potential confounders, the RRs across the lowest to the highest WC quintiles 
were 1.00, 1.11, 1.17, 1.31 and 1.71 (95% CI, 1.47 to 1.98) for all-cause mortality; 
1.00, 1.04, 1.04, 1.28, and 1.99 (95% CI 1.44 to 2.73) for CVD mortality (all P<0.001 
for trend); the RRs across the lowest to the highest WHR quintiles were 1.00, 1.09, 
1.14, 1.33, 1.59 (95% CI 1.41 to 1.79) for all-cause mortality; 1.00, 0.99, 0.93, 1.05, 
1.63 (95% CI 1.27 to 2.09) for CVD mortality (all P<0.001 for trend). This study 
concludes that anthropometric measures of abdominal adiposity were strongly and 
positively associated with all-cause and CVD mortality independently of BMI in 
women. 
 
In US, the Third National Health and Nutrition Examination Survey (NHANES III) 
provided a set of standardized measurements of body size and composition in a 
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representative sample of the US population. Based on this survey, Jared and 
colleagues conducted a study for comparison of overall and body fat distribution in 
predicting risk of mortality [77]. WHR in women (P<0.001 for trend) was positively 
associated with mortality in middle-aged adults (30–64 years), while BMI and WC 
exhibited U- or J-shaped associations. Among middle-aged men and women, J-shaped 
associations of BMI with CVD mortality were observed. CVD mortality was 2.8- and 
3.2- fold higher across quintiles of WC in middle-aged men and women respectively; 
5.4- and 4.1- fold higher across quintiles of WHR. The reference groups are the 
lowest WC or WHR quintile categories. The authors concluded that ratio measures of 
body fat distribution were strongly and positively associated with mortality and 
offered additional prognostic information beyond BMI and WC in middle-aged adults. 
Jared and colleagues also investigated the association of overall obesity and 
abdominal adiposity in predicting risk of all-cause mortality in white and black adults 
[78]. This prospective study included a national sample of 3219 non-Hispanic white 
and 2561 non-Hispanic black adults 30 to 64 years of age enrolled in NHANES III. 
During 12 years of follow-up (51,133 person-years), 188 white and 222 black adults 
died. After adjustment for confounders, positive dose-response associations between 
WHR and mortality in white and black women were observed (all P<0.05 for trend). 
These results were unchanged after additional adjustment for BMI. In contrast, BMI 




























359, 387 EU 34.6 25-70 9.7 All-cause mortality:  
BMI  nonlinear  
WC   linear  




9206 Australia 49.0 20-69 11 All-cause mortality 
BMI  not significant  
WC   
Men   not significant 
Women  linear 
WHR  linear 
CVD mortality  
BMI   
Men   linear   
Women   not significant  
WC   linear 




41, 313 Australia 41.1 27-75 11 All-cause mortality 
BMI  U shaped 
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BMI  U shaped 
WC   U shaped 
WHR  linear 
CVD mortality 
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5780 U.S. 45.6 30-64 12 All-cause mortality 
BMI  curvilinear-shaped 
WC   curvilinear-shaped 
WHR   
Men   not significant 
Women  linear 
 
2.4.3 Discussion  
 
2.4.3.1 Methods  
 
The study designs of the seven studies are cohort studies. They have used Cox 
proportional hazards models to estimate the HR or RR for mortality. In five out of 
seven papers, the analyses were conducted in females and males separately and they 
reported gender differences in the associations between adiposity and mortality. In 
these seven papers, the usually adjusted covariates are age, smoking status, alcohol 
use, physical activity and education. Two studies used age instead of follow-up time 
as the underlying time variable. Using age as the time axis allows the baseline hazard 
to change as a function of age, which is a better method for controlling the potential 
confounding due to age. Most of the studies grouped the subjects into quintiles or 
quartiles categories of WC, WHR or BMI at baseline. Three studies conducted 
sensitivity analysis excluding subjects with comorbidities and those experiencing 
early death during follow-up. Several studies conducted subgroup analysis for age 
groups and smoking status.  
 
2.4.3.2 Results  
 
Most studies observed a nonlinear association between BMI and all-cause mortality. 
In the EPIC study, there was a significant nonlinear association of BMI with the risk 
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of death [67]. In the Melbourne Collaborative study, the associations between BMI 
and all-cause mortality were U shaped for both men and women [76]. In the study 
conducted on white and black adults in the US, BMI exhibited curvilinear-shaped 
associations with mortality [78]. In another US study based on NHANES III, U and J 
shaped associations of BMI with mortality in men and women were observed 
respectively [77]. 
 
Most studies suggest a linear association between WHR and mortality, especially in 
women. In the Nurses‟ Health study, the researchers reported after adjustment for age, 
smoking and other covariates, increasing WHR was strongly associated with a graded 
increase in all-cause mortality. In stratified analysis, the associations of WHR with 
mortality were not appreciably different between never and ever smokers, between 
older and younger women and between premenopausal and postmenopausal women 
[55]. In the EPIC study, after adjustment for BMI, WHR was strongly associated with 
the risk of death [67]. In the Australia Heart study, WHR was superior by magnitude 
and significance in predicting all-cause mortality [74]. In the Melbourne 
Collaborative study, the researchers found a linear trend of all-cause mortality across 
incremental quintiles of WHR in women [76]. In the study conducted on white and 
black adults in the US, WHR in women were strongly and positively associated with 
mortality in a dose-response fashion. The association was independent of overall 
obesity (reflected by BMI) [78]. In another US study based on NHANES III, graded 
hazard ratios of mortality across incremental quintiles of WHR in middle-aged 
women were noted [77]. In the seven papers, most findings support an independent 
contribution of body fat distribution to mortality and the importance of abdominal 
adiposity in predicting mortality in women.  
 
Table 1 summarizes the empirical evidences reported from the seven studies. It is 
difficult to compare the magnitude of RR or HR across studies due to differences in 
the categories and reference category chosen for the modeling of the anthropometric 
measures. Variations in these risk estimates are likely to reflect differences in the 
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measurement, the populations examined, baseline age of participants in the study, 
follow-up time, and confounders adjusted for in multivariable Cox regression models. 
 
2.4.3.3 Limitations  
 
There were some limitations in these studies. First, all the seven studies had only a 
single baseline assessment of adiposity measurements and other exposures; therefore, 
they could not examine whether the changes in these variables during the follow-up 
period had any influence on the outcome. Second, there may be residual cofounding 
in some studies. For example, in the EPIC study, although people who had a history 
of cancer, heart disease, or stroke were excluded, the analysis may have included a 
number of participants who had other serious diseases that could potentially confound 
the observed associations [67]. Third, some studies in the seven papers suggest that 
smoking may change the pattern of association between adiposity and mortality. This 
association should be investigated in healthy persons who have never smoked. 
However, several studies have limited power to perform subgroup analysis by 
smoking status. Fourth, because the study population was predominantly Caucasians, 
the results may not be generalized. The findings require confirmation in other ethnic 
groups. 
 
2.4.4 Studies in Asian Populations 
 
Most studies on overweight, obesity and fat distribution and mortality are based on 
studies from the North America and Europe. Studies have shown that the relationships 
among BMI, body fat percentage (BF%) and body fat distribution differ across 
populations [79]. Asians generally have a higher percentage of body fat than 
Caucasians of the same age, sex and BMI [15]. For a given amount of total body fat, 
Chinese and most South Asians had more visceral fat than the Europeans [80]. 
Moreover, not all Asians will have similar body fat composition [81]. Even between 
Chinese groups living in Beijing, Hong Kong and Singapore, there seemed to be 
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differences in the BMI/BF% relationship [82]. In addition, Asian populations have 
different associations between BMI, BF% and health risks than American and 
European populations [83, 84]. Obesity-associated metabolic risks are greater in 
Asian people than in European populations since Asian tend to have lower BMI but 
higher fat volume. Lean individuals can show increased risk of CVD and other 
metabolic and inflammatory disorders if they present accumulated fat in the 
abdominal region [84, 85]. 
 
Studies examining the role of various anthropometric variables and mortality in Asia 
are relatively sparse [59, 60, 86, 87], and few have examined whether the distribution 
of body fat contributes to the prediction of death. In Singapore, we have also shown 
overweight (BMI 25kg/m2) to be associated with all-cause mortality in women [88]. 
Increased risk of mortality was also apparent for individuals in the underweight 
(<18.5 kg/m
2
) and obese BMI categories (27.5 kg/m2) independent of age and 
smoking [89]. However, the above mentioned and previous studies in Asia have relied 
predominantly on BMI to assess the association between adiposity and mortality [41, 
60, 87-90]. In Asia, only two studies investigated the relationships between central 
obesity and mortality. In the Japanese Community-Based Studies, the authors reported 
WC was associated inversely with increased risk of all-cause death in men, but not in 
women. CVD mortality risk was increased in men aged≤65 years with a higher WC. 
This relationship was U-shaped. WC was not associated with all-cause or CVD 
mortality in women [91]. Only the investigators of the Shanghai Women‟s Health 
Study compared the effect of body fat distribution (WHR, WC and waist-to-height 
ratio) on mortality after adjustment for BMI in relatively lean Chinese women [92]. 
Data from this prospective cohort study with the follow-up period extended to the end 
of 2007 suggested the associations between BMI, WC and WHR with mortality in 
Chinese women [93]. In addition, results from published studies to date that have tried 
to compare different measurements of general and regional adiposity have not been 
consistent [94]. At the present time, there is a lack of prospective epidemiological 
studies in Asian populations where different anthropometric measures as predictors of 
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mortality are compared. 
 
2.4.5 Section Conclusions  
 
Although there is no agreement on which anthropometric measures could be better 
predictors of mortality, our review suggests that anthropometric measures of 
abdominal obesity may be stronger predictors of mortality than BMI, especially in 
women. However, the unexplained heterogeneity highlights the need for additional 
well designed observational studies to evaluate the effects of adiposity on mortality. 
There is a lack of studies in Asian populations. Hence, a comparison of 
anthropometric measures as predictors of all-cause and CVD mortality in Asian 
















In this study, we will investigate the relationship between several anthropometric 
measures of adiposity (BMI, WHR, WC and waist residual [WR]) with all-cause and 
CVD mortality and also compare, where possible, different anthropometric measures 
as predictors of mortality in an Asian cohort.  
 
3.2 Study Design  
 
This will be a prospective study using data from subjects who participated in the 1992 
National Health Survey or the National University of Singapore Heart Study 
(1992-1995). The two studies were nationwide surveys undertaken to determine the 
risk factors for the major non-communicable diseases in Singapore.  
 
The 1992 National Health Survey was conducted between September and November 
1992 at six community centers distributed around Singapore Island. The survey team 
moved systematically each fortnight, through Silat, Toa Payoh, Fengshan, Ang Mo 
Kio, Ulu Pandan, and Chong Pang community centers over the 3-month period, to 
provide island-wide coverage of survey sites and proximity to those selected. A total 
of 4915 individuals were randomly selected from a sample of all household units in 
Singapore, obtained from the Department of Statistics‟ National database on 
dwellings in Singapore. The characteristics of the selected sample conformed with 
that of the resident population. Systematic sampling, followed by disproportionate 
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stratified sampling by ethnic groups, was used to select the sample for the survey. The 
two minority groups, Malays and Asian Indians, were oversampled to give an ethnic 
distribution of 60% Chinese, 20% Malays, and 20% Asian Indians. This was to ensure 
sufficient numbers for statistical analysis, and representative results were weighted 
back during the analysis of findings. From the 4915 eligible individuals randomly 
selected from a sample of all household units in Singapore, 3568 Singapore residents 
aged between 18 and 69 years finally participated in the survey. The response rate 
was 72.6%. Although response rates did differ between ethnic groups, the 
nonresponders were contacted and information was sought regarding their 
demographic and socioeconomic profile and diabetes and hypertension status. This 
was to ensure that the prevalence of these diseases would not be underestimated 
during the survey. Characteristics of the nonresponders were similar to those of the 
survey respondents [95]. 
 
The National University of Singapore Heart Study was a random sample of people 
aged 30 to 69 years from the general population of Singapore. The sample was 
obtained from electoral registers of five divisions, each in a different part of the island 
(north, south, east, west, and centre). There was disproportionate sampling in relation 
to ethnic groups to obtain equal numbers of subjects in each of the six gender-ethnic 
groups. The required sample was 180 subjects in each gender-ethnic group giving a 
total of 1080 subjects. Assuming that 20% of the subjects would not be recruitable 
because of death, migration, infirmity, or relocation (which is high in Singapore due 
to massive urban redevelopment), and assuming a response rate of 75%, a total of 
1800 persons was selected. Of these, 419 (23.3%) were not recruitable and 983 
responded, giving a response rate of 71.2%. Of the 983 subjects, 22 were 70 years or 
over and were excluded, leaving 961 persons aged between 30 and 69 years [96]. 
 
Of the 4529 participants from the two cross-sectional surveys, individuals with 
pre-existing coronary heart disease or prior cerebrovascular accident and belonging to 
an ethnic group other than Chinese, Malay or Asian Indian were excluded. Individuals 
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with missing data for anthropometric variables or other covariates were also excluded. 
Thus a total of 4318 participants were included in the cohort.  
 
3.3 Data Collection  
 
Weight, height, waist and hip circumference were measured at baseline according to 
standardized protocols. Weight (in kilograms) was measured in subjects in light 
clothing using the electronic weighing scales. Height (to the nearest millimeter) was 
recorded in all subjects without shoes. BMI was calculated as weight in kilograms 
divided by height in meters squared. Waist (defined as the narrowest part of the body 
below the costal margin) and hip (defined as the widest part of the body below the 
waist) measurements were also taken, and the WHR was computed. Interviewer 
administered questionnaires captured age, gender, ethnic group and the use of alcohol 
and cigarettes.  
 
All-cause mortality and CVD mortality were obtained by linking individual records 
(using the National Registry Identity Card [NRIC] number that is unique to all 
Singaporean citizens) to the Singapore Registry of Births and Deaths. The registration 
of deaths is a compulsory requirement in Singapore and certification is only done by 
medical practitioners. All outcomes were in coded form using the ninth revision of the 
International Classification of Diseases (ICD-9). All-cause mortality included all 
deaths that occurred in the cohort up till 31 December 2004. The primary cause of 
death was used. CVD mortality included all deaths due to ischaemic heart disease 
(IHD) (ICD-9410–414) and cerebrovascular accidents (ICD-9430–438). All 
individuals were followed up till death or censored at 31 December 2004, whichever 
occurred first.  
 




All questionnaires and physical examination/blood test forms were checked for 
completeness. Double data entry was done which allowed quality control checks.  
 
3.5 Data Analysis 
 
Type I error for all statistical tests is set at 0.05 (5%). All statistical analyses are 
conducted using STATA version 11, unless otherwise stated.  
 
3.5.1 Univariate Analysis 
 
Continuous and categorical variables are summarized using appropriate summary 
measures, depending on the distributions of the variables. Differences in baseline 
characteristics between men and women were tested by Student‟s t-test for continuous 
variables and by Chi-square tests for categorical variables.  
 
3.5.2 Waist Residual Score 
 
Waist residual score was calculated as WC minus the value predicted by the 
regression of WC on BMI in each gender group. The residuals method has been 
introduced in nutritional epidemiology by Willett and Stampfer and has been 
previously utilized in the evaluation of independent associations of waist and hip 
circumferences with cardiovascular risk factors [97]. Residual scores are often used to 













3.5.3 Cox Proportional Hazards Model 
 
Cox, in 1972, developed a modeling procedure termed Cox‟s proportional hazards 
model for analyzing survival data when the number of prognostic factors is large. The 
model helps to assess the effect of various prognostic factors on survival after 
adjusting each for the other factors. Cox‟s proportional hazards model is analogous to 
a multiple regression model and enables the difference between survival times of 
particular groups of patients to be tested while controlling for other factors [98, 99]. 
 
The model can be written as: 
   
    
     
                   
Where       and        are the hazard and baseline hazard at time t,      is the 


















ratios (HRs). The estimate of   , denoted   , is obtained from the data of the 
particular study concerned.  
 
In this model, the response variable is the „hazard‟. The hazard is the instantaneous 
probability of death given that an individual has survived up to a given point in time, t. 
In Cox‟s model, no assumption is made about the probability distribution of the 
hazard. However, it is assumed that the HR does not depend on time. In other words, 
the HR is constant over time. The strength of the model developed by Cox is not only 
that it allows survival data arising from a non-constant hazard rate to be modeled, but 
it does so without making any assumption about the underlying distribution of the 
hazards in different groups, except that the hazard in one group remains proportional 
to the other group over time [98-100].  
 
In our study, person-years of follow-up were calculated from the date of the baseline 
examination until the date of death or 31 December 2004 for each study participant. 
Sex-specific Cox proportional hazards regression models were used to evaluate the 
relationship between standardized scores (Z-scores) of BMI, WC, WR and WHR with 
all-cause and CVD mortality with HR and 95% CI. When the event of interest was 
CVD mortality, non-CVD events were treated as being censored. Z-score 
transformation allows the comparison of effect of different anthropometric variables. 
The HR indicates the increased risk for 1 SD increase of each anthropometric variable. 
The proportional hazards assumption was checked for all outcomes studied. 
Second-order polynomial terms were used to evaluate nonlinear relationships between 
anthropometric measures and mortality. Models were all adjusted for age (continuous), 
ethnic group (Chinese, Malay, India), smoking status (current, former or never) and 
alcohol consumption (<1, ≥ 1 drinks per month). Presence of diabetes, hypertension, 
blood glucose, blood pressure and lipids were not adjusted for as they were 
considered as potential mediators. Partial correlations between all of the 
anthropometric variables were computed, adjusting for age. Anthropometric variables 
that were not highly correlated (r < 0.7) [101] were subsequently included together in 
25 
 
the same Cox proportional hazards model in order to determine the effect of these 






4. Results  
 
4.1 Baseline Characteristics of the Study Population 
 
Table 2 provides the descriptive characteristics of the sample at the baseline whereas 
Table 3 provides the partial correlations of anthropometric variables. There are 2091 
males and 2227 females. Women and men differed significantly with respect to the 
anthropometric variables. Women had lower height, weight, WC and WHR compared 
with men. A greater proportion of men were current smokers and drank alcohol 
compared with women, although they were not significantly different in age, race, 
BMI and WR. After adjusting for age, there is very strong correlation between BMI 
and WC (r=0.826) in women; very strong correlation between BMI and WC (r=0.867), 









Table 2. Characteristics of the study population by gender  
 
 Man Woman  P-value 
N 2091  2227   
Age(years)  40.0 (13.6)  39.8 (12.6)   0.623 
Race
＊
    0.855 
Chinese 1221(58.4)  1315(59.1)   
Malay 446 (21.3)  460(20.6)   
Indian 424 (20.3)  452(20.3)   
Height (cm) 167.8(6.6) 155.4 (6.0)  <0.001 
Weight (kg) 66.0 (12.0) 56.9 (11.2)   <0.001 
BMI (kg/m2)  23.3 (3.8)  23.4 (4.6)  0.190 
Waist circumference(cm)  81.3 (10.8) 73.2 (11.1)   <0.001 
Waist-to-hip ratio  0.85 (0.07) 0.75 (0.07)  <0.001 
Waist Residuals (cm)  0 (5.5)  0 (6.0)   1.000 
Current smoker 
＊
 739 (35.3)  63(2.8)   <0.001 
Alcohol consumption
＊
    <0.001 
< once per month 1732 (82.8)  2167(97.3)   
>= once per month 359(17.2)  60(2.7)   
＊
Categorical variables: numbers and column percentages 
 Continuous variables: means and standard deviation 
 
 
Table 3. Partial correlation adjusted for age between anthropometric variable at 
baseline 
 
 BMI WC WR WHR 
   Women  
BMI  0.826 -0.125 0.439 
WC 0.867  0.456 0.786 
WR -0.082 0.426  0.690 
WHR 0.608 0.841 0.577  
  Men   
P<0.001 
BMI, body mass index; WC, waist circumference; WR, waist residual; WHR, waist-to-hip ratio 









4.2 Anthropometric Variables and All-cause and CVD Mortality in 
men  
 
Assessment of each of the anthropometric variables showed that there were nonlinear 
significant associations for BMI, WC and WHR with all-cause mortality (Table 4). To 
assess the independent contribution of the various anthropometric measures to 
all-cause mortality, we included different anthropometric variables in the same model. 
Of note BMI and WC are highly correlated and were not included in the same model. 
The quadratic term for BMI (BMI
2
) was significantly associated with all-cause 
mortality (Table 5) when either WR or WHR were included in the model. The 
association between WHR and all-cause mortality was attenuated slightly, but 
achieved borderline significance when BMI was included in the model. Only WC was 











Table 4. Associations between anthropometric variables and mortality in men  
 
Model   Terms  HR (95%CI) per SD increase P-value 
All death    
Model1            
 BMI 0.99 (0.82 - 1.20)  0.953  
 BMI2 1.08 (1.02 - 1.15)  0.013  
Model2    
 WC  0.90 (0.75 - 1.08)  0.243  
 WC2 1.22 (1.12 - 1.32) <0.001 
Model3    
 WR 1.00 (0.84 - 1.19)  0.990  
 WR2 1.02 (0.97 - 1.06) 0.454  
Model4    
 WHR 0.98 (0.79 - 1.23)  0.890  
 WHR2 1.11 (1.01 - 1.22)  0.030  
CVD death    
Model1            
 BMI 1.16 (0.83 - 1.63)  0.376  
 BMI2 1.04 (0.93 - 1.17)  0.481  
Model2    
 WC  0.97 (0.70 - 1.34)  0.862  
 WC2 1.16 (1.00 - 1.36)  0.050  
Model3    
 WR 0.94 (0.64 - 1.38)  0.753  
 WR2 0.96 (0.77 - 1.19)  0.688  
Model4    
 WHR 1.10 (0.72 - 1.69)  0.650  
 WHR2 1.00 (0.81 - 1.24)  0.997  
Model 1, Model 2, Model 3 and Model 4 include variables listed and also age, race,  
smoking and alcohol consumption. 
 
Regression equations for models in Table 4: 
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Table 5. Models for the prediction of mortality from indicators  
of overall adiposity and adipose distribution in men 
 
Model   Terms  HR (95%CI) per SD increase P-value 
All death    
Model1            
 BMI 0.99 (0.82-1.20)  0.926  
 BMI2 1.09(1.02-1.16)  0.010  
 WR 1.06 (0.88-1.27)  0.543  
Model2    
 BMI  0.94(0.73-1.22)  0.656  
 BMI2  1.09(1.01-1.16)  0.019  
 WHR  1.03(0.77-1.38)  0.843  
 WHR2  1.09(0.99-1.21)  0.083  
CVD death    
Model1            
 BMI 1.27 (0.90 - 1.80)  0.178  
 WHR 0.94 (0.63 - 1.43)  0.787  
Model2    
 BMI 1.23 (0.92 - 1.64)  0.161  
 WR 0.92 (0.68 - 1.24)  0.568  
Model 1 and Model 2 were models adjusted for age, race, smoking group and  
alcohol consumption group. 
 
Regression equations for models in Table 5: 
 




   
    
     
                                                             




   
    
     
                                                            
                                                                             
 






   
    
     
                                                   




   
    
     
                                                  






4.3 Anthropometric Variables and All-cause and CVD Mortality in 
Women  
 
All four measures of adiposity were associated with all-cause and CVD mortality in 
women without adjusting for confounders. Quadratic terms in the models were not 
statistically significant. After adjustment for age, ethnicity, smoking and alcohol 
intake, only WR (HR 1.21; 95%CI: 0.98-1.49) remained marginally significant for 
all-cause mortality. For CVD mortality, only WHR (HR 1.55; 95%CI: 0.98-2.43) was 
found to be marginally significant (Table 6). 
 
To further assess the effect of different anthropometric variables, BMI was combined 
with WR or WHR, as similar to men; since WC was highly correlated with BMI. WC 
was not combined with BMI. After adjustment for BMI, WR remained a marginally 
significant predictor of all-cause mortality in women (HR 1.21; 95%CI: 0.98-1.49); 
However for CVD mortality, when BMI and WHR was included in a model, WHR 











Table 6. Associations between anthropometric variables and mortality in women 
 
Model   Terms  HR (95%CI) per SD increase P-value 
All death    
Model 1    
 BMI 1.00 (0.78 - 1.27) 0.973 
Model 2    
 WC 1.13 (0.89 - 1.44) 0.325 
Model 3    
 WR 1.21 (0.98 - 1.49) 0.079 
Model 4    
 WHR 1.20 (0.92 - 1.57) 0.181 
CVD death    
Model 1    
 BMI 0.98 (0.66 - 1.45) 0.909 
Model 2    
 WC 1.16 (0.78 - 1.73) 0.459 
Model 3    
 WR 1.21 (0.90 – 1.62) 0.206 
Model 4    
 WHR 1.55 (0.98 - 2.43) 0.059 
Model 1, Model 2, Model 3 and Model 4 include variables listed and also age, race,  
smoking and alcohol consumption. 
 
Regression equations for models in Table 6: 
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Table 7. Models for the prediction of mortality from indicators  
of overall adiposity and adipose distribution in women  
 
Model   Terms  HR (95%CI) per SD increase P-value 
All death    
Model 1    
 BMI 1.01 (0.79 - 1.30) 0.915 
 WR 1.21 (0.98 - 1.49) 0.079 
Model 2    
 BMI 0.93 (0.71 - 1.21) 0.572 
 WHR 1.24 (0.93 - 1.65) 0.144 
CVD death    
Model 1    
 BMI 1.03 (0.69 - 1.53) 0.90 
 WR 1.21 (0.90 – 1.64) 0.210 
Model 2    
 BMI 0.89 (0.59 - 1.35) 0.59 
 WHR 1.58 (1.00 – 2.49) 0.048 
Model 1 and Model 2 include variables listed and also age, race, smoking and 
alcohol consumption. 
 
Regression equations for models in Table 7: 
 




   
    
     
                                                  




   
    
     
                                                    
                                                                                            
 





   
    
     
                                                  




   
    
     
                                                    
















In this study, men showed a statistically significant U-shaped relationship between 
BMI, WC and WHR and all-cause mortality. Most of the effects of obesity on 
all-cause mortality were captured by BMI. Of the measures of central obesity, only 
WHR showed a borderline association with all-cause mortality that was independent 
of BMI. WC was not an independent predictor of all-cause mortality, as suggested by 
the lack of association between WR and mortality. In contrast, in women, all four 
measures of adiposity showed a linear relationship with all-cause mortality. However, 
after adjusting for age, ethnicity, smoking and alcohol intake, only WR showed a 
borderline association with all-cause mortality. WHR showed a borderline association 
with CVD mortality which was statistically significant after including BMI in the 
model. 
 
Our study contributes to the literature in several ways. Firstly, it confirms the 
U-shaped association between BMI and all-cause mortality in men, that has been 
demonstrated in China [87] and Korea [59]. In this study, we extend this U-shaped 
relationship to include measures of central obesity, WC and WHR. In the Canada 
Fitness Survey, significant J shaped relationships in men were observed between BMI 
and WC and all-cause mortality rate [102]. A U-shaped relationship between WC and 
mortality was also observed in the NHANES III study [77], although the quadratic 
term was not statistically significant in that study. The frequently observed U-shaped 
relationship between BMI and mortality rate may be due to the opposing effects of fat 
mass and fat-free mass components of BMI on mortality rate [103]. However, the 
U-shaped association between WC and WHR, which are not affected by fat free mass, 
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and mortality in men suggest that this is not the case. Another possible explanation is 
that BMI is a poor anthropometric measure to diagnose obesity. The percentage of 
body fat for a given BMI is highly variable [104] and if so, our study suggests that 
this applies to WC and WHR as well. 
 
Secondly, our study suggests, at least in men, that the association between WC and 
mortality is largely mediated through its co-linearity with BMI. No independent 
association was observed between WC and mortality. In recent years, there has been 
increasing speculation over which measure of overweight and obesity is best able to 
discriminate those individuals who are at increased mortality risk. The most 
appropriate adiposity marker for assessing the risk of death is debated [76, 77, 95, 102, 
105-108]. BMI is the most frequently used measure of obesity because of the robust 
nature of the measurement of weight and height [14]. However, BMI cannot 
differentiate between lean and fat mass nor can it account for differences in relative 
fat distribution.  
 
The metabolic effects of abdominal adiposity are well established. Greater abdominal 
adiposity is closely associated with adverse metabolic profiles such as insulin 
resistance, dislipidemia, and systematic inflammation, which play essential roles in 
the pathogenesis of CVD and diabetes mellitus [109]. Adipose tissue from visceral fat 
deposits secretes potential mediators in the development of chronic diseases [13]. 
Paradoxically, increased lower body fat does not confer the same risk of CVD and 
insulin resistance as the same amount of fat in the upper body; lower body fat appears 
to exert a protective effect [110]. A number of epidemiological studies have 
demonstrated that measures of abdominal adiposity significantly predict chronic 
diseases such as CVD and diabetes mellitus independently of overall adiposity [32]. A 
meta-analysis shows that indices of abdominal obesity are better discriminators of 
cardiovascular risk factors than BMI in both men and women [19]. The use of WC 
has been proposed because it is more strongly related to visceral fat and may therefore 
be a risk indicator of mortality caused by visceral fat. However, enlarged WC 
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generally reflects increased fat deposition either in the subcutaneous or visceral layers. 
As a consequence, WC and BMI are highly correlated. In our study, we were not able 
to detect any independent association between WR and mortality despite previous 
findings that waist circumference residual scores after adjustment for BMI was more 
closely associated with increased total body fat mass than fat free mass [111] and can 
provide specific information about regional fat distribution. WHR is less strongly 
related to BMI than is WC and is therefore a more specific surrogate for fat 
distribution. An increased WHR may reflect a relative abundance of visceral fat, 
decreased peripheral fat or muscle, or both. Alternatively, a low WHR may reflect a 
relative lack of visceral fat, increased muscle or peripheral fat, or some combination 
[77]. Thus, the combination of waist circumference with hip circumference may 
provide a unique estimation of body shape or fat distribution. Some researchers have 
shown that WHR is the most useful measure of obesity, and is the best and simple 
anthropometric index in predicting a wide range of risk factors and related health 
conditions [14]. Our findings showing a borderline association between WHR and 
all-cause mortality in men, and between WHR and CVD mortality in women are in 
line with these previous findings.  
 
Finally, our findings suggest the possibility that the relationship between various 
anthropometric measures of adiposity and mortality are gender dependent in Asians. 
The U-shaped relationship between obesity and mortality observed in men was not 
seen in women. Furthermore, only WHR (and not BMI, WC or WR) showed a 
statistically significant association with mortality (specifically CVD mortality) after 
adjustment for age, ethnic group, smoking and alcohol intake. However, it seems 
important to consider BMI when assessing the relationship between WHR and CVD 
mortality. We would point out that these associations are very marginal in terms of 
statistical significance, and these findings must be taken with that in mind. 
Nonetheless, in the Hong Kong Cardiovascular Risk Factor Study, the authors 
reported the impact of sex-specific body composition on cardiovascular risk factors. 
After adjustment for BMI, hip circumference independently and inversely contributed 
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to CVD risk in women but not in men, unlike in Caucasians where the relationship 
was identified in both sexes. Increasing adjusted waist circumference was associated 
with increased risk of hypertension, diabetes and dyslipidemia in Chinese women 
only [112]. In another study comprising of Chinese women, WHR was positively and 
significantly associated with risk of death from CVD in a dose-response fashion 
(P<0.01 for trend) [92]. In the Nurses‟ Health Study, increasing WHR were associated 
with a graded increase in CVD mortality independent of BMI (P<0.001 for trend). 
Spline regression also showed a linear association of WHR with CVD mortality [55]. 
In the Norwegian HUNT 2 study, WHR predicted CVD mortality in women (P<0.001 
for trend) [71]. In an Australian study, WHR was the dominant risk factor predicting 
cardiovascular death in women [113]. 
 
The strength of our prospective study includes its high follow-up via data linkage, 
relatively long duration of follow-up and direct measure of the anthropometric 
measures. Our anthropometric measures were made by direct physical examination 
according to standard protocols as opposed to self-reported data. This eliminated the 
possibility of any bias from self-reporting.  
 
Our study does have some potential limitations. The principle limitation of this study 
was the relatively small sample size and modest numbers of events. In studies 
assessing the association of obesity with mortality, two sources of biases are likely to 
be particularly important [114]. One of them is the problem of reverse causality. 
Weight loss can be the result, rather than the cause, of underlying illness. To avoid the 
impact of reverse causality, exclusion of deaths in the early period of follow-up, 
exclusion of participants with existing disease or recent weight loss are required. 
Second, smoking is an important confounder that might mask true effect of obesity. 
Smoking is associated with reduced weight and is also an important determinant of 
mortality. Simple adjustment for smoking categories in multivariable models may be 
insufficient to fully control for its effect and lead to residual confounding. One way to 
get around this problem is to examine the effect of obesity on mortality only among 
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never-smokers. However, due to the relatively young age of the cohort, the number of 
deaths is not large and this limits the statistical power of the study and the possibility 
to address the two types of biases in the statistical analyses. Moreover, for public 
health and clinical recommendations, it is not sufficient to know whether an 
anthropometric measure is a significant predictor or not, but it is also important to 
define the most favorable range for interventions. Grouping participants according to 
categories of anthropometric measures would allow for more detailed examination of 
the associations. However, the sample size and the number of deaths are too limited 
for such detailed analyses. In addition, although anthropometric variables are reliable, 
quick and inexpensive to administer, these measures could not distinguish fat from fat 
free mass. Hence, it is important to explore these issues with sophisticated imaging 
techniques that incorporate direct measurements of body composition. Further 
research to carefully assess body composition may yield novel insights into the 








6. Future Work 
 
There are several areas in which future research could be undertaken. 
 
6.1 More Accurate Measures of Fat Composition   
 
The traditional approaches for measurements of body fat are anthropometric measures. 
The advantages of anthropometric measures such as BMI and WHR are inexpensive, 
widely available and portable, qualities that make it attractive for field studies or 
population based studies [49]. However, these measurements also include lean tissue 
and bone and therefore are not direct measures of fat content.  
 
BMI and other surrogate measures of fatness are widely used in community studies 
and adopted by international organizations for a few basic applications, such as 
surveillance of secular trends or regional variations [15, 52]. However, there are 
certain important circumstances where there is a mismatch between the surrogate 
measures (especially BMI) and true body fatness, which results in the surrogate 
measures giving misleading information. In a large representative sample of the US 
population, bioelectrical impedance analysis (BIA) was used to estimate BF%. Abel 
and colleagues found that in men BMI correlated significantly better with lean mass 
than with BF% [58]. Okorodudu and colleagues have performed a systematic review 
and meta-analysis on the diagnostic performance of BMI to indentify obesity. 
Commonly used BMI cutoff values have high specificity but low sensitivity to 
identify adiposity (Included studies used a body composition technique as the 
reference standard for BF% measurement) [115]. Frankenfield and colleagues 
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reported that measurement of body fat (using impedance-derived body fat mass as the 
criterion) is a more appropriate way to assess obesity in people with a BMI below 30 
kg/m
2
 [116]. In addition, in recent years there has been an increasing awareness that 
certain ethnic groups display a very different relationship between BMI and body fat 
to that described for Caucasians [32]. Many Asian races tend to carry a 
proportionately higher fat mass for a given BMI than Caucasians. In Chinese 
population, Chen and colleagues concluded that BMI was correlated with BF% (body 
fat was estimated from Body Composition Analyzer). However, BMI had its 
limitations in the interpretation of subjects with BMI between 24 and 27.9 kg/m
2
 [51]. 
The above examples illustrate that the simple anthropometric measures of body fat 
can give misleading information concerning the true body composition of an 
individual or group of individuals owing to a mismatch in the usual relationship 
between lean and fat tissue [52]. 
 
In future, greater attention should be paid to the development of standards based on 
the direct measurement of body fat in population, rather than on surrogate measures. 
It is rather remarkable that there is little data on body fat content and no normative 
standards that can be used as clinical or surveillance tools. We should be making 
greater efforts to actually assess body fat and to develop population standards against 
which individuals could be compared.  
  
6.2 Prediction Equation  
 
BF% and visceral fat are appealing direct measures of fatness because the medical 
literature suggests that it is fat that causes morbidity and mortality [32]. And it is not 
just the amount of fat that matters, but also the location or distribution of the fat [17, 
32]. Simple anthropometric methods, such as WHR, WC are widely used. However, 
these methods cannot differentiate between visceral and subcutaneous fat and are less 
accurate [47]. Techniques for direct measurement of visceral fat such as CT are 
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expensive, time-consuming or require a relatively high radiation dose [117]. Effective 
methods for assessing BF% or visceral fat are important to investigate the role of 
body fat for the increased health risks. In future work, we can generate prediction 
equations for BF% or visceral fat, so researchers using a dataset that include 
anthropometric measures could estimate these more accurate measures of fatness.  
 
Equations that predict body fat from anthropometric measurements allow the 
estimation of body composition without complex and costly techniques, and they can 
be used easily for on-field assessment, to provide adequate information that is 
required in clinical and research practice, especially in low budget and field settings 
[118]. In Europe, the age- and sex- specific equations of Durnin & Rahaman and 
Durnin & Womersley relating skinfold thickness at four sites to BF% are widely used 
[119]. The anthropometric prediction equation can provide useful information about 
the percentage of body fat, thus eliminating the need to scan participants with 
technologies such as DXA. In Asians, there are a limited number of 
anthropometry-based prediction equations for the estimation of BF% in adults. Using 
DXA as the reference method, future study could construct and validate prediction 
equations for BF% from anthropometric measures. In addition, there are also 
relatively few studies which investigate the relationships between anthropometric 
variables and visceral fat. Janssen and colleagues found that BMI and WC 
independently contribute to the prediction of visceral fat in Caucasian men and 
women [54]. Snijder and colleagues reported that for the prediction of visceral fat, the 
sagittal diameter, which has a practical advantage compared to DXA, is just as 
effective [120]. In Japanese adults, Demura and colleagues proposed a prediction 
equation for visceral fat area at the umbilical level from WHR and internal fat mass 
based on three skinfolds [121]. They also developed equations to predict visceral fat 
area at the umbilicus level using fat mass of the trunk measured by DXA and BIA 
[122]. Kuk and colleagues found that hip circumference, thigh circumference and 
BMI are positively associated with total, lower-body and abdominal subcutaneous 
adipose tissue and skeletal muscle mass but negatively associated with visceral 
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adipose tissue after adjustment for WC [123]. 
 
The use of anthropometric measures as surrogates of body fat differs by ethnicity and 
equations that have been derived in western population are often not suited for other 
populations [79]. At the present time, there is little systematic data available in 
Singapore regarding the comparison of anthropometric measures of adiposity to a 
standard reference method such as DXA or CT. Therefore, it is meaningful to develop 
prediction equations to estimate body composition in Singapore in future work. 
 
6.3 Body Composition and Cardiometabolic Risk Factors. 
 
Studies indicate that obesity closely associated with a number of metabolic and 
cardiovascular risk factors including high-fasting glucose, hypertension, dislipidemia 
and high-sensitively C-reactive protein levels [20, 124-132]. However, most studies in 
the literature focused on the associations between anthropometric measures and 
cardiometabolic risk factors [20, 124-128]. The use of BMI, WHR and WC as a single 
anthropometric index of cardiovascular and metabolic risk is limited by the fact that 
for a given measurement value, there may be large variations in the level of total body 
fat and in the level of abdominal visceral adipose tissue that are most likely to be 
associated with important variations in the metabolic profile [63, 133]. Jennifer and 
colleagues also found that when using BMI to define obesity, approximately one third 
of obese individuals were metabolically healthy [134]. Studies in the literature have 
evaluated the ability of commonly used anthropometric indices in identifying 
cardiovascular risk factors [20, 124-132]. The best adiposity measurement for 
identifying cardiovascular risk factors remains controversial [127]. Moreover, 
although the overall correlations between anthropometric measures and 
cardiometabolic risk factors appear to be significant, the magnitude of associations 
were small [20]. The prediction of cardiovascular risk factors by anthropometric 
indices has limitations. Reasonable explanations are anthropometric indices as 
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indicators of obesity are inadequate and are not reliable in individuals [135].  
 
The investigations into the roles of fat and lean body mass are not only highly 
appropriate, but timely. First, fat and lean body mass are more accurate measurements 
of body composition than anthropometric methods [46]. Second, to our knowledge, 
the role of fat mass and lean mass in relation to cardiovascular risk factors has not 
been studied in a population based study in Singapore. Knowledge regarding direct 
indices of adiposity in relation to cardiometabolic risk factors can have significant 
impact on the prevention of obesity, type 2 diabetes and CVD. Although 
anthropometric measurements have the advantage of being simple and inexpensive 
parameters, direct assessment of body fat mass and lean mass may be better indexes 
of obesity because they correlate better with cardiometabolic risk factors. In further 
study, gender-specific cutoffs of direct indices of fat mass and lean body mass could 
be used for clinical and research purpose to detect cardiovascular risk factor and for 
categorizing obesity in Singapore. Greater understanding about the associations 
between fat and lean body mass and cardiovascular risk factors will result in the 
development of innovative and more effective therapeutic strategies and better quality 
of life for the patients.  
 
6.4 Body Composition and Obesity Prevention 
  
Accurate determination of body fat could provide clinically useful guidance for 
physicians to assess disease risks in patients with obesity and optimize the preventive 
or therapeutic remedies for these patients. In addition, for a given BMI, Asian 
populations were noted to have higher BF% and higher cardiovascular risk factors 
than Western populations [81, 82]. We estimate that in Singapore, many people with 
normal BMI but higher body fat mass may be unaware of their heightened 
cardiometabolic risk. Because self-awareness of a condition is the initial step in 
behavioral modification and incorporation of therapeutic lifestyle changes, it might be 
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relevant to incorporate fat mass and lean mass measurement in the regular physical 
exam. This can help us to focus on early recognition and treatment of risk factors and 
symptoms instead of end-stage treatment of chronic diseases. From a clinical 
perspective, assessment of indicators of body composition may contribute to a better 
evaluation of an individual‟s risk for CVD. Measures of body composition and body 
fat distribution that are both simple and direct could help stratify individuals 
according to their level of body fat and preserved lean mass. The significance of 
differentiating between lean mass and fat mass are not only for adequate risk 
assessment and accurate prognosis but also to determine appropriate interventions. 
For example, weight loss without preservation of lean mass might be harmful and 
















7.  Conclusion  
 
In summary, we confirmed the U-shaped association between BMI and all-cause 
mortality and extended these findings to include WC and WHR in men. WC (either as 
directly measured or calculated as a residual) did not provide additional information 
that helped predict mortality in men or in women. In contrast, WHR appeared a better 
predictor of mortality. Our study also suggests that the relationships between 
measures of adiposity and mortality may differ between genders. General adiposity 
appears to be a significant predictor of all-cause mortality in men, more so than 
central adiposity. Although measures of central adiposity were better predictors of 
CVD mortality in both men and women as compared with measures of general 
adiposity, there was a difference in that the association was U-shaped for men and 
linear for women. This type of heterogeneity may result in the differing findings from 
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This is a medical survey. 
 
 
The information is confidential and available only to the doctors in the survey. 
 
 
If you require any treatment, you will be informed. 
 
 
If you have any questions, please ask the attending doctor. 
 
 
The study findings will help us improve the health of the people of Singapore. 
 
 










                                              Blood taken 
                                              
                                              Interviewed 
 
                                              Measurements 
 
                                              Doctor 
 





Source  1. Thyroid and Heart Study  2. Corolipid Study  3 General population        
 
Name:______________________ Serial Number                                     
 




________________________________    Interviewer __________________ 
 
 
Tel. No. ___________________________ Interview language/dialect _________  
 
 




1. DEMOGRAPHIC  
 
 1 When did you last take food or drink (except water)?____________Hrs fasting     
 
1.2 Sex                                  1. Male   2. Female 
 
1.3 What is your date of birth?  _____/______/_______ (day/month/year) 
 






1.5 What is your ethnic group? 






                      2. OCCUPATION 
 





3. Unemployed/seeking work 
4. Unemployed/sick or disabled 
5. Student 




2.2 What is (was) your present (last) job? ___________________________________   
 
2.3 If Female, What is (was) your husband’s present (last) job? __________________              
 
 
                        3. EXERCISE 
 
3.1 How much physical activity do (did) you have in your present ( last ) job? 
1. Mostly sitting 
2. Moderate activity 
3. Much activity 
 
3.2 (i) Do you take active exercise, e.g. jogging, sports?       1. No  2. Yes 
    
   If No. go to 4.1  
 
  (ii) What type of activity is this?_______________________________________  
 
 (iii) How many times a month (on average) do you do this activity? __________ 
 
 (iv) Do you exercise for at least 15 minutes fairly continuously during each session? 
1.No    2. Yes 
 
 (v) Do you exercise till you perspire and breathe deeply during each session? 





4.1 (i) Would you describe your present alcohol intake as : 
1. None/Special occasions only 
2. Once or twice a month 
3. Once or twice a week 
4. Daily/most days 





 (ii) How many drinks do you usually take on those days that you drink? 
( a drink is a single spirit, glass of wine, or small beer) ___________________ 
 
 
                   5. CIGARETTE SMOKING 
 
5.1 (i) Do you smoke cigarettes now?                   1. No    2. Yes 
 
If No, go to 5.2 
 
(ii) On average how many cigarettes do you smoke a day?____________________ 
 
(iii) How old were you when you began to smoke cigarettes?_________________ 
 
5.2 (i) Did you ever smoke cigarettes?                  1. No     2. Yes 
 
If No, go to 6.1 
 
(ii) On average how many cigarettes did you smoke a day?__________________ 
 
(iii) How old were you when you began to smoke cigarettes?________________ 
 
(v) How old were you when you stopped smoking cigarettes?_______________ 
 
(vi) Why did you stop ?_______________________________________________ 
 
 
                    6. CHEST PAIN ON EFFORT 
 
6.1 ( i ) Have you ever had any pain or discomfort in your chest ?   1. No  2. Yes  
 
If No, go to 7.1 
 
(ii) How old were you when you first had the pain or discomfort? _____________ 
 
6.2 Do you get it when you walk uphill or hurry?                1. No  2. Yes 
 
6.3 Do you get it when you walk at an ordinary pace on the level?  1. No  2. Yes 
 
If No to 6.2 and 6.3, go to 7.1 
 
6.4 What do you do if you get it while you are walking?  
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1. Carry on 
2. Stop, slow down or take medicine 
 
6.5 If you stand still, does it go away?           1. No   2. Yes 
 
If No, go to 7.1 
 
6.6 How long does it take to go way? 
                                1. More than 10 minutes 
                                2. 10 minutes or less 
 
6.7 Where do you get this pain or discomfort? 
(record all areas indicated) 
1. Upper or middle sternum 
2. Lower sternum 
3. Left anterior chest 
4. Left arm 
5. Others (specify)___________ 
 
 
                      7. POSSIBLE INFARCTION 
 
 7.1 Have you ever had a severe pain in your chest lasting for half an hour or more? 1. No  2. Yes 
 
If No, go to 8.1 
 
7.2 How many of these attacks have you had?________________________________________ 
 
7.3 How old were you when you had the first attack?_________________________________ 
 
 
                     8. CARDIOVASCULAR DISEASES AND DIABETES 
 
8.1 (i) Has a doctor ever told you that you hd angina?                  1. No   2. Yes 
 
If Yes:  (ii) What was your age at that time?__________________________________________ 
 
8.2 (i) Has a doctor ever told you that you had a heart attack?            1.No   2. Yes 
 
If Yes:  (ii) What was your age at that time?__________________________________________ 
 
8.3 (i) Has a doctor ever told you that you had high blood pressure?       1. No   2. Yes 
 





8.4 (i) Has a doctor ever told you that you had diabetes mellitus?          1.No   2.Yes  
 
If Yes:  (ii) What was your age at that time?__________________________________________ 
 
8.5 Has any member of your immediate family ( father, mother, brother, sisters) ever suffered 
from? 
 
Angina or a heart attack:    1. No   2. Yes   Relatives________________________________ 
 
High blood pressure:       1. No   2. Yes   Relatives________________________________ 
 
Diabetes mellitus:         1. No   2. Yes   Relatives________________________________ 
 
 
                             9. DIET 
 
9.1 Are you on any of the following special diets? 
 
                                 Weight reducing:    1. No     2. Yes  
 
                                 Diabetic:           1.No     2. Yes 
 
                                 Low fat:            1. No     2. Yes 
 
                                 Low salt:           1.No      2. Yes  
 
                                 Vegetarian:         1.No      2. Yes  
 
 
         10. PREGNANCY AND PILL ( For all females below 50 years)  
 
10.1 Are you pregnant?                                    1. No     2. Yes 
 
10.2 Are you on the contraceptive pill?   1. No   2. Yes   Specify_____________________ 
 
 
          11. ADVICE FROM DOCTOR ( For “Thyroid and Heart Study” subjects) 
 
11.1 Did you consult your doctor after your check-up about 10 years ago? 
                                                       1. No      2. Yes 
 





                       12. DEATH ( if applicable) 
 
12.1 Date of death: __/___/____(day/month/year) 
 
12.2 Cause of death:____________________________________________________________ 
 
12.3 Source of information on cause of death:________________________________________ 
 
 
                     13. EXAMINATION         DOCTOR___________________ 
 
13.1 BLOOD PRESSURE                     Blood Pressure 1   S1____________ 
 
                                                        D5____________ 
 
                                       Blood Pressure 2   S1_____________ 
 










                           Angina:                  1. No   2. Yes 
 
                           Myocardial Infarction:       1. No   2. Yes  
 




What medicines are you now taking?_____________________________________ 
Complete below if relevant 
 
Antihypertensive   1. No    2. Yes   Specify:_______________ Have you taken this drug in 
the last 48 hrs?      1. No     2. Yes  
 
Diuretic          1. No    2. Yes   Specify:_______________ Have you taken this drug in 
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the last 48 hrs?      1. No     2. Yes  
 
Lipid lowering     1. No    2. Yes   Specify:_______________ Have you taken this drug in 
the last 48 hrs?      1. No     2. Yes  
 
Insulin           1. No    2. Yes   Specify:_______________ Have you taken this drug in 
the last 48 hrs?      1. No     2. Yes  
 
 
                        14. MEASUREMENTS 
 
14.1  Height ( to nearest 0.5 cm)_________________ 
 
14.2  Weight ( to nearest 0.1 kg)___________________ 
 
14.3  Wait ( to nearest 0.1 cm)____________________ 
 
14.4  Hips( to nearest 0.1 cm)____________________ 
 
14.5  Electrocardiogram ( Minnesota Code)____________ 
 
14.6  Angiogram______________________ 
 
 
                     15. INVESTGATIONS 
 
15.1 Lipoproteins 
                        Triglyceride  ( mmol/l) 
 
                        Total cholesterol  ( mmol/l) 
 
                        HDL cholesterol  ( mmol/l) 
 
                        LDL cholesterol  ( mmol/l) 
 
                        VLDL cholesterol  ( mmol/l) 
 
                        Apo A-1  (mg/dl) 
 
                        Apo B  (mg/dl) 
 
                        Lp (a)  (mg/dl) 
15.2 Haematology  
                        Fibrinogen  (g/l) 
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                        Factor VIIc  (Iu/ml) 
 
                        tPA  (ng/ml) 
 
                        PAI-1  (Iu/ml) 
 
                        Prothrombin Fragment F1+2  ( nmol/l) 
15.3 Diabetes 
                        Glucose  ( mmol/l) 
 
                        Insulin  ( miu/l)  
 
        OGTT:   0 hrs    Glucose  ( mmol/l) 
 
                        Insulin  ( miu/l) 
 
OGTT:   1 hrs    Glucose  ( mmol/l) 
 
                        Insulin  ( miu/l) 
 
OGTT:   2 hrs    Glucose  ( mmol/l)  
 
                        Insulin  ( miu/l) 
 
Diabetes:  1. No                                   2. Yes ( diagnosed lst survey) 
              3. Yes ( diagnosed since lst survey)           4. Yes ( diagnosed this survey) 
 
15.4 Vitamins 
                   A    Beta-carotene  (ug/ml) 
 
                        Retinoid     (ug/ml) 
 
                        Trans-retionol (ug/ml) 
 
                   E    Alpha-tocopherol (ug/ml) 
 
                        Gamma-tocoperol (gu/ml) 
 
                   C    Vitamin C (ug/ml) 
 
15.5 Minerals        Selenium (ug/l) 
 





                            
NATIONAL HEALTH SURVEY, 1992 
 






2. NRIC No.: 
___________________________________________________________ 
3. Sex 
1.  Male 
2.  Female 
___________________________________________________________ 
4. Ethnic Group : 
1.  Chinese 
2.  Malay 
3.  Indian 
___________________________________________________________ 
5. Date of Birth: 
___________________________________________________________ 
6. Marital Status: 
                       1.  Single 
                       2.  Married 
                       3.  Divorced/widowed/separated 
 
 




8.a) Have you ever been told by a doctor (Western-trained) that you have Diabetes? 
                       1. Yes 
                       2. NO 
 b) if “ YES”: 
   Are you currently on regular medication from your doctor (Western-trained)? 
1. Yes (Exempted from OGTT) 





A- PERSONAL PARTICULARS 
B- FASTING STATUS 
C- DIABETIC STATUS 










9. Height/Weight                     Reading 1  Weight (kg) 
                                             Height (cm) 
       Recorder No.  
                                   Reading 2  Weight (kg) 
                                             Height (cm) 
   
10.a) Waist/Hip Girth 
                                   Reading 1   Waist (cm) 
                                              Hip (cm) 
       Recorder No.  
                                   Reading 2   Waist (kg) 
                                              Hip (cm) 
 
                                   Reading 3*  Waist (kg) 
                                              Hip (cm) 
(* Only to be done if there is a difference of more than 2cm between Readings 1 & 2 
in either waist &/or hip measurements) 
 
 b) Triceps Skin Fold Thickness (mm) 
 









11. Blood Pressure                       Reading 1   Systolic (mmHg) 
                                                 Diastolic (mmHg) 
       Recorder No.  
                                      Reading 2   Systolic (mmHg) 
                                                 Diastolic (mmHg) 
 
                                      Reading 3*  Systolic (mmHg) 
                                                 Diastolic (mmHg)          
(* Only to be done if there is a difference of more than 20% between Readings 1 & 2 
in either Systolic &/or Diastolic blood pressure) 
 
 
12. Plasma glucose (venous, fasting) (mmol/L) 
D- PHYSICAL EXAMINATION 




13. OGTT Results (2hr plasma glucose (venous)) (mmol/L) 
 
14. Plasma lipids (fasting) (mmol/L)                      Total Cholesterol 
 
                                                   LDL 
 
                                                   HDL 
 
                                                   Triglycerides 
 
                                                   Apolipoprotein A1 
 
                                                   Apolipoprotein B 
 
15. Serum insulin (fasting) (mU/L) 
 
   Serum insulin (2 hr post glucose load (mU/L) 
 
   Serum uric acid (µmol/L) 
 
   Serum creatinine (µmol/L) 
 




17. a) Occupational status : 
                       1. Working (record occupation below) 
                       2. Unemployed (record previous occupational below) 
                       3. Retired (record previous occupational below) 
                       4. Housewife 
                       5. Student 
 
  b) Occupation:_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
___________________________________________________________________ 
18. Highest level of Education Attained: 
                       1. No formal education 
                       2. PSLE 
                       3. GCE ‘O’ Level 
                       4. GCE ‘A’ Level/diploma 




19. Level of occupational physical activity (Relate to occupational status and 
occupation indicated in Q.17 above and probe respondent if in doubt): 
F- SOCIO-ECONOMIC PROFILE 




                       1. Sedentary (eg. office worker, Unemployed, retired, 
student)  
                       2. Light (eg. Sales, housewives) 
                       3. Moderate (eg. Craftsman) 
                       4. Heavy (eg. Construction) 
_____________________________________________________________________ 
20. a) In the past month, did you participate in any sports or exercises?             
                       1. Yes 
                       2. No (Go To Q.21) 
 
   b) if “YES”: 
    
(i) What were the sports or exercises that you participated in (each session 
should have lasted for at least 30 minutes); and  
(ii) How many times in the past month did you go for each of those activities? 
01. Running/jogging 
02. Brisk walking 
03. Swimming                  Activity  No. of times in past month 
04. Cycling                       (each time lasting at least 30 mins) 
05. Aerobic exercise             
06. Basketball                (i) 
07. Netball 
08. Sepak takraw             (ii)   
09. Soccer 
10. Squash                  (iii)  
11. Badminton 
12. Table tennis              (iv)   
13. Tennis 
14. Social dancing            (V) 
15. Taichi/yoga                




21. Have you ever smoked cigarettes before?                                 
 
1. Yes 
2. No, never (Go to Q.25) 
_____________________________________________________________________ 
22. Which of the following categories do you belong to now?  
 
1. Previously experimented with smoking (Go to Q.25) 
2. Ex-smoker (smoked regularly for at least 6 months before but have stopped 
smoking completely) (Go to Q.24) 
3. Occasional smoker(smoke less than 7 cigarettes/week) (Go to Q.25) 
4. Regular smoker (smoke at least 7 cigarettes/week) (Go to Q.23) 




For Regular Smoker Only  
 
23. a) On average, how many sticks of cigarettes do you smoke a day?   
 
   b) At what age did you start smoking regularly?   
 
Go to Q.25 
_____________________________________________________________________ 
For Ex-Smoker only  
 
24. a) How long ago did you stop smoking cigarettes?  
         1. Less than 6 months 
         2. 6 months to 1 year 
         3. More than 1 year 
  b) Hong long did you smoke before you stopped smoking?  
 
  c) What were the two MAIN reasons that made you stop smoking? 
   (Please rank them accordingly) 
 
1. Advised to stop smoking by doctor 
2. Learnt about ill effects of smoking from mass-media/health fair/nurse 
3. Cigarettes have become too expensive 
4. Fewer places to smoke in, due to banning of smoking in public areas 
5. Family/peer pressure 
6. Do not get a kick out of smoking anymore 




25. Do you consume alcohol? 
             1. Yes 
             2. No (Go to Q.29) 
_____________________________________________________________________ 
For those who drink only 
 
26. How often do you have alcoholic drinks? 
             1. Daily/most days (4-7 days a week) 
             2. 1 to 3 days a week 
             3. 1 to 3 days a month 
             4. Less than once a month (eg. on special occasions such as 
Christmas, New Year, social gatherings etc.)  
_____________________________________________________________________ 
27. a) What is your MAIN alcoholic drink?  
             1. Beer 
             2. Stout 
             3. Wines 
I- ALCOHOL INTAKE 
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             4. Spirits (gin, whisky, rum,brandy, vodka) 
             5. No specific preference 
  b) How many cans/bottles/glasses of this do you usually drink on any one 
occasion? 
_____________________________________________________________________ 
28. During the past month, have you ever had 5 or more drinks on any one occasion? 
(If “YES”, Probe : How many occasions?) 
(A drink is 1 can/small bottle of beer, 1 glass of wine or 1 measure (peg) of spirits) 
1. No 
2. Yes, one occasion 
3. Yes, two occasions 










3. Don’t know 
 
   b) If “YES”:  Specify relationship (up to a maximum of 3 members):              






6. Grandmother  
 
If respondent is not a known Diabetic (i.e. “No” to Q.8a), Go to Q.31 
_____________________________________________________________________ 
 
For Diabetics only (i.e. if “YES” to Q.8a) 
 
30. a) How many years have you had diabetes?                                
   b) Does your doctor (Western-trained) currently prescribe any tablets/insulin 
injections for your diabetes? 
                1. Yes 
                2. No (Go to Q.30d) 
   c) If “YES”: are you taking the tablets/insulin injections prescribed by your doctor 
(Western-trained)? 
                1. Yes 
                2. No (Go to Q.30d) 
If you are on tablets/insulin injections, are you following the amounts and frequency 
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as prescribed by your doctor (Western-trained)? 
1. Yes 
2. No, reduce what has been prescribed 
3. No, increase what has been prescribed 
d) Do you try to control your diabetes by taking any particular foods/traditional 
medicine? 
            1. Yes 
            2. No (Go to Q.30f) 
e) If “YES”: What do you take? (May indicate more than one answer)           
            1. Certain fruits or vegetables (specify)_ _ _ _ _ _ 
            2. Herbal/traditional medicine 
f) (i) What other measures or lifestyle changes do you practice to control your 
diabetes? 
  (ii) What measures or lifestyle changes, if any, did your doctor advise you for 
your diabetes? 
 Measure (Read Out)                              Practice?  Advice? 
                                             (1.Yes 2.No)  (1.Yes 2.No) 
1. Lose weight/maintain ideal weight 
 
2. Reduce food intake 
 
3. Reduce intake of simple carbohydrates 
(eg. sugar, white rice, white bread, etc) 
 
4. Increase intake of complex carbohydrates/high 
fiber food (eg. wholemeal bread, brown rice, vegetables) 
 
5. Reduce fat intake 
 
6. Cutting down/stop smoking 
 




9. Special care of feet/toes 
 
10. Others (specify): _ _ _ _ _ _ _  
 
g) To your knowledge, is your diabetes now under control?                         
      1. Yes 
      2. No (Go to Q.31) 
      3. Don’t know (Go to Q.31) 
 
h) If “YES”: 
(i) How do you know that your diabetes is under control? 
  Was it based on- (May indicate more than one answer) 
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1. Blood test by doctor/nurse 
2. Urine test by doctor/nurse 
3. Own blood test 
4. Own urine test 
5. Feel well (Go to Q.31) 
 
(ii) if a test was done, how long ago was the most recent test done? 
1. Less than 1 month 
2. 1 to 3 months 
3. 4 to 6 months 
4. More than 6 months 
 
HYPERTENSION 
31. Have you ever been told by a doctor (Western-trained) that you have high blood pressure? 
   1. Yes 
   2. No 
_______________________________________________________________________________
32.a) Has anyone in your family ever had high blood pressure?                                  
1. Yes 
2. No 
3. Don’t know 
 
b) If “YES”: Specify relationship (up to a maximum of 3 members): 
  1. Father 
  2. Mother                                                (i)  
  3. Brother 
  4. Sister                                                 (ii)  
  5. Grandfather 
  6. Grandmother                                          (iii)  
 
If “No” to Q.31, Go to Q.34 
____________________________________________________________________________ 
For Hypertensives only (i.e. if “YES” to Q.31) 
 
33.a) How many years have you had high blood pressure?                   
   
   b) Does your doctor (Western-trained) currently prescribe any tablets for your high blood 
pressure? 
      1. Yes 
      2. No (Go to Q.33d) 
    
c) If “YES”: Are you taking the tablets prescribed by your doctor (Western-trained)? 
   1. Yes 
   2. No (Go to Q.33d) 
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  If you are on tablets, are you following the amounts and frequency as prescribed by 
your doctor (Western-trained)? 
1. Yes 
2. No, reduce what has been prescribed 
3. No, increase what has been prescribed 
 
      d) Do you try to lower or control your blood pressure by taking any particular 
foods/traditional medicine? 
         1. Yes  
         2. No (Go to Q33f) 
 
      e) If “YES”:  What do you take? (May indicate more than one answer) 
         1. Certain fruits or vegetables (specify):_ _ _ _ _ _ _  
         2. Herbal/traditional medicine 
33. f) (i) What other measures or lifestyle changes do you practice to control your blood 
pressure?  
     (ii) What measures or lifestyle changes, if any, did your doctor advise you for your high 
blood pressure?  
 
        Measure  (Read Out)                       Practice ?        Advice?  
(1.Yes  2.No)     (1. Yes  2. No) 
1. Lose weight                                   
 
2. Reduce salt intake 
 
3. Reduce fat intake 
 




6. Cutting down/stop smoking 
 
7. Reduce alcohol intak 
 
8. Reduce/cope with stress 
 
9. Others (specify): _ _ _ _ _ _ _ _  
 
g) To your knowledge, is your blood pressure now under control?                         
      1. Yes 
      2. No (Go to Q.34) 
      3.Don’t know (Go to Q.34) 




(i) How do you know that your blood pressure is under control?                       
Was it based on-(may indicate more than one answer) 
1. Information from doctor/nurse 
2. Own recording 
3. Feel Well ( Go to Q.34) 
(ii) If your blood pressure was checked, how long ago was the most recent check done?  
1. Less than 1 month 
2. 1 to 3 months 
3. 4 to 6 months 




34. Have you ever been told by a doctor (Western-trained) that you have ischaemic heart 
disease/coronary heart disease/angina (manifested by chest pain on exertion) or had a heart 
attack? 
      1. Yes                                                                      
      2. No 
 
35. Have you ever had a stroke before ( manifested by numbness or weakness/paralysis on one 
side of the body affecting one side of the face, one arm and one leg lasting either less or more 
than 24 hours)? 
     1. Yes                                                            
     2. No 
 
If Male, Skip Q.36 & Q.37 
 
COMMON PREVENTABLE CANCERS AMONG WOMEN 
 
PAP Smears 
( A PAP Smear is a simple test involving the scraping of cells from the mouth of the womb to 
detect early cancer) 
 
36. a) Have you ever had a PAP Smear test?                                                
      1. Yes 
      2. No (Go to Q.36c) 
      3. Don’t know (Go to Q.36c) 
 
   b) If “ YES”: 
     
(i) Hong long ago have you had your last smear done?     
1. Less than 1 year 
2. 1 to 3 years 
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3. More than 3 years 
 
(ii) Where was your last smear done? 
1. MCH clinic 
2. Government specialist clinic  
3. Private medical clinic/hospital, done by a gynaecologist 
4. Private medical clinic, done by a general practitioner 
5. Singapore Cancer Society 
6. Others (specify):_ _ _ _ _ _ _ _ 
 
c) Do you think it is important to have a PAP Smear test ? 
       1. Not important 
       2. Important 




37.a) Have you ever had your breasts examined by a doctor or nurse? 
        1. Yes 
        2. No (Go to Q.37c) 
  b) If “YES”: How long ago was it that you had such an examination? 
 
1. Less than 1 year 
2. 1 to 3 years 
3. More than 3 years 
   
  c) Have you been taught Breast Self-Examination by a doctor or nurse? 
        1. Yes 
        2. No 
  
  d) How often do you perform breast examination on yourself?  
        1. At least once a month 
        2. Once in every few months 
        3. Less often 
        4. Never 
 
  e) Do you think it is important to have a breast examination (whether by doctor/nurse/self)? 
        1. Not important 
        2. Important 






































Survey Form Checked By: 
Staff No.                  Date :_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _   
  
K-CHECKLIST (please () after completion of each procedure 
 Fasting Blood Specimen                    Height/Weight 
Glucose Load:                            Waist/Hip Girth 
        Given                        Blood Pressure 
.   Exempte    ECG ( For males aged more than 35 years only) 
                                   2 Hr Blood Specimen 
 
38. Glucose Load                         (Time given)   
________________________________________________________________
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